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Abstract
End-stage renal disease (ESRD) patients undergoing
hemodialysis (HD) are at high risk of arrhythmias and
sudden cardiac death as a result of blood potassium con-
centration ([K+]) changes. The aim of this study is
to investigate if dw, a time-warping-based electrocardio-
gram (ECG) biomarker of T-wave morphology changes,
reflects [K+] evolution in HD patients, facilitating non-
invasive [K+] monitoring and avoiding in-hospital blood
tests analysis. 48-hour ECGs and a set of hourly-collected
blood samples from 12 ESRD patients were acquired and
analyzed. dw was calculated between a reference T-wave,
measured at the end of the HD session, and the T-waves
corresponding to each hour along the whole HD session,
when [K+] was measured from blood samples. The val-
ues of dw correlated with the relative variations in [K+]
with respect to the reference value (end of HD, ∆[K+]),
with a median (interquartile) correlation coefficient of 0.90
(0.30), evidencing a strong relation between them. Our
findings support the use of dw as a surrogate of ∆[K+],
suggesting a potential use of dw for non-invasive hyper-
kalemia monitoring both in hospital and ambulatory set-
tings.
1. Introduction
Variations in blood potassium concentration (∆[K+])
can alter the spatio-temporal ventricular repolarization se-
quence, resulting in abnormal dispersion of ventricular re-
polarization and thus increasing the susceptibility for ma-
lignant arrhythmias [1, 2].
End-stage renal disease (ESRD) patients undergoing
hemodialysis (HD) have a high prevalence of arrhythmias
[3] and high cardiovascular (CV) mortality rates [1] due
to fluctuations of [K+] out of normal ranges (3.5 mmol/L
≤ K+ ≤ 5 mmol/L) [2]. Currently, all the routine tests
to assess [K+] require blood analyses, an invasive and
costly procedure that limits a continuous monitoring [4].
A non-invasive ambulatory index able to quantify changes
in [K+] levels would be an important advance for both in-
hospital and out-hospital continuous monitoring.
Abnormalities in ventricular repolarization are reflected
on the electrocardiogram (ECG) signal, in particular, on
the T-wave morphology [5]. Different ECG biomarkers
have been previously reported to be correlated with [K+]
levels, including the T-wave slope-to-amplitude ratio [6] or
the T-wave right slope [7]. However, these biomarkers rely
on specific local features of some parts the T-wave, but ne-
glect the information contained in the whole T-wave mor-
phology. In this study, we investigated the ability of dw,
a time-warping-based ECG marker of T-wave morphology
changes, with known association with ventricular repolar-
ization dispersion [8], to monitor changes in [K+] levels in
ESRD patients undergoing HD.
2. Study Population and Protocol
A standard, 12-lead 48-hour ECG Holter recording
(H12+, Mortara Instruments, Milwaukee, WI, USA, sam-
pling frequency 1000 Hz, amplitude resolution 3.75 µV)
and [K+] concentrations from blood samples were col-
lected from 12 ESRD patients undergoing HD at Hospi-
tal Clı´nico Universitario Lozano Blesa (Zaragoza, Spain).
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Table 1 shows the population characteristics. The study
protocol was approved by the ethical committee and all pa-
tients signed informed consent. The ECG recording started
5 minutes before the HD onset and lasted for 48 hours (Fig-
ure 1 blue line). Simultaneously, six blood samples were
acquired and analyzed during the HD session: the first one
at the HD onset and the next three every hour during the
HD session (Figure 1, K1 to K4 in red). The 5th blood
sample was collected at the end of the HD (minute 215th
or 245th, depending on the HD session duration) while the
6th blood sample was taken after 48 hours, immediately
before the next HD session.
Table 1. Characteristics of the study population.
Characteristics All (n=12)
Age (years) 70(11)
Gender (male) 7(58%)
Anti-arrhythmic drugs (yes) 6(50%)
HD session duration
240 min 10(83%)
210 min 2(17%)
Kidney disease etiology
Diabetes mellitus 7(58%)
Interstitial nephritis 1(9%)
Tuberous sclerosis 1(9%)
Other 3(25%)
HD liquid Composition
Potassium (1.5 mmol/L) 12(100%)
Calcium (3 mmol/L) 8(67%)
* Values are expressed as number (%) for categorical variables
and median (interquartile range) for continuous variables
Figure 1. Diagram of the study protocol. K1 to K6 are the
time points (in minutes) for blood sample extraction. K5
was taken at the end of the HD (minute 215th or 245th,
depending on the HD duration).
3. Methods
3.1. ECG pre-processing
Initial ECG pre-processing included low-pass filtering
with cut-off frequency at 40 Hz to remove muscular and
powerline noise, and 0.5 Hz cut-off high-pass filtering to
attenuate baseline wander. QRS complexes were detected
and delineated using a wavelet-based single-lead delin-
eation method applied to each of the 12 leads [9]. Prin-
cipal component analysis was applied to the 8 independent
leads. Principal components (PCs) were obtained from
the auto-correlation matrix of T-waves computed in a sta-
ble ECG segment at the end of the HD session. Then,
the whole ECG recording was projected into the direction
given by the PC1. This way, the energy of the T wave in
this component was maximized, allowing better morpho-
logical characterization [10]. The T-waves were further
delineated by applying the same delineation method [9] to
PC1.
3.2. T-wave morphology changes quantifi-
cation by time-warping
The T-waves from PC1 were selected from a 2-min win-
dow centered on the 5th minute of each available hour
(Figure 2 (a)), as this is when the blood samples were col-
lected during HD. The window was narrow enough to al-
low the assumption of stability in heart rate and [K+] lev-
els. A mean warped T-wave (MWTW) was computed from
the T-waves in each 2-min window [8]. For this, all the T-
waves within each window were aligned with respect to
their gravity center and used to compute an initial average
warped T-wave [8]. Only those T-waves highly correlated
(Spearman’s correlation coefficient > 0.98) with this ini-
tial average warped T-wave were used to recalculate the
MWTW, which is representative of the T-wave morphol-
ogy in that particular time window. The MWTW at the
end of the HD treatment was taken as the reference, given
that it is when the patient (i) has recovered the normal [K+]
level and (ii) is discharged from hospital, consequently be-
ing an appropriate reference for out-hospital ambulatory
monitoring until next HD session.
Let’s consider each hourly MWTW, fs(ts) =
[fs(ts(1)), ..., fs(ts(Ns))]
>, and the reference MWTW,
fr(tr) = [fr(tr(1)), ..., fr(tr(Nr))]
>, respectively, from
the red and blue squares in Figure 2 (a); where tr =
[tr(1), ..., tr(Nr)]
> and ts = [ts(1), ..., ts(Ns)]> and Nr
and Ns are the total duration of tr and ts. As an exam-
ple, let’s assume fs(ts) as the MWTW from the 1st hour
(red filled square in Figure 2 (a)), then fs(ts) = f1(t1),
ts = t1 and Ns = N1. Figure 2 (b) shows the two tr
and t1 MWTWs before the time-warping. Let γ(tr) be
the warping function that relates tr and t1, such that the
composition [f1 ◦ γ](tr) = f1(γ(tr)) denotes the re-
parameterization or time domain warping of f1(t1) using
γ(tr). The square-root slope function (SRSF) was pro-
posed [11] to find the optimal warping function by warping
the SRSFs of the original T-waves. This transformation is
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defined as:
qf (t) = sign
(
f˙ (t)
)√∣∣∣f˙ (t)∣∣∣ (1)
The optimal warping function is the one that minimizes
the amplitude difference between the SRSF of fr(tr) and
f1(γ(tr)) [11]:
γ∗ (tr) = argmin
γ(tr)
(∥∥qfr (tr)− q[f1◦γ] (tr)∥∥) (2)
= argmin
γ(tr)
(∥∥∥qfr (tr)− qf1 (γ (tr))√γ˙ (tr)∥∥∥)
The dynamic programming algorithm was used to obtain
the solution of this optimization problem [12]. The opti-
mal warping function, γ∗(tr), that optimally warps fr(tr)
and f1(t1) is shown in Figure 2 (c). The warped T-wave,
f1(γ∗(tr)) is shown in Figure 2 (d), together with the ref-
erence T-wave, fr(tr).
The index dw (Figure 2 (c)) quantifies the level of warp-
ing needed to optimally align any two T-waves as the av-
erage of the absolute difference value between γ∗(tr) and
tr:
dw,1 =
1
Nr
Nr∑
n=1
|γ∗ (tr (n))− tr (n) | (3)
This was repeated for each hour.
The relative variations in [K+] with respect to the refer-
ence values (end of treatment), during the HD session were
computed as:
∆[K+] = ([K+]s − [K+]r) (4)
4. Results
None of the 12 ECG recordings lasted 48h, mainly due
to electrode detachment or early battery exhaustion. This
limited the association between dw and the last [K+] sam-
ple (after 48h). For that reason, Spearman’s correlation
coefficients were computed considering only the first five
values of ∆[K+] and dw (those obtained during the HD
session). The median (interquartile range) value computed
over all the intra-subject Spearman’s correlation coeffi-
cients was found to be 0.90(0.30), indicating a significant
correlation between ∆[K+] and dw. Figure 3 shows the
distribution of dw and ∆[K+] during the HD session.
5. Discussion
Evaluation of [K+] levels is usually performed by inva-
sive procedures, based on blood samples that require fur-
ther laboratory analyses. However, it is known that the
ECG can reflect changes correlated to [K+] variations.
ESRD patients undergoing HD present important [K+]
Figure 2. Illustration of dw computation for a subject un-
dergoing a 240-min HD session. The average RR interval
is shown in panel (a) with squares depicting the measure-
ment windows when dw was computed during the ECG
acquisition. The filled red square is the measurement at
the beginning of HD and the filled blue square is the refer-
ence time at the end of HD. In panel (b), the reference (in
blue) and the MWTW computed for the first hour (in red)
are shown. Panel (c) shows the warping function (red line)
that optimally relates them and the green area is the total
warping information, quantified by dw. Panel (d) shows
the final warped T-waves.
Figure 3. Distribution of ∆[K+] (in blue, left vertical-
axis) and dw (in red, right vertical-axis), computed at dif-
ferent time points from the beginning to the end of the HD
session (K1 to K5 in Figure 1).
level fluctuations during the treatment, generating related
ECG signal variations. Indeed, during the first hour of the
HD procedure, [K+] quickly decreases. This acute fall in
[K+] is followed by a more gradual decline over the next 2
hours. During the final hour, [K+] remains almost stable,
indicating equilibrium between the rates of [K+] removal
and the rate of re-equilibration from intracellular space.
After HD treatment ends, a sub-acute rebound of [K+] oc-
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curs as continued mobilization of [K+] from intracellular
to extracellular space occurs.
As explained in [7], action potential duration in endo-
cardial, mid-myocardial and epicardial myocytes are dif-
ferently affected by extracellular [K+] and this is reflected
mostly on the ECG as T-wave changes. This makes the
analysis of T-wave morphology changes a suitable [K+]
level sensor. In this work, we have shown how HD-induced
electrolyte changes affect T-wave morphology. The intra-
subject Spearman’s correlation coefficients computed be-
tween ∆[K+] and dw during the HD session are remark-
able: the median value computed over all the enrolled par-
ticipants is 0.90 and interquartile range 0.3, supporting our
initial hypothesis. Based on the evidences provided in this
study, dw is suggested as a non-invasive index able to cap-
ture fluctuations in [K+]. Therefore, dw could be used to
monitor patients susceptible to [K+] disorders. Its capacity
for arrhythmic risk prediction could be assessed as well in
those populations. The advantage of dw as a non-invasive
automated surrogate for [K+] trend monitoring is that it
would reduce the costs of [K+] invasive assessment, cur-
rently requiring blood test analyses, being especially suit-
able for daily routine check outside hospital environments.
There are several limitations in this study that should
be acknowledged. First, the reduced number of patients
enrolled in the study limited the statistical power of the
results. Second, the lack of blood samples after the HD
session limits the comparison between dw and ∆[K+]
over that period.Nevertheless, the high correlation between
∆[K+] and dw opens a new way to non-invasively monitor
[K+] level changes.
Future studies should assess the correlation between
dw and alterations in other electrolytes beyond [K+], like
magnesium or calcium. These variations can actually al-
ter the ECG and it would be interesting to analyze their
relationship with the induced T-wave changes. This could
shed more light into ECG alterations in ESRD patients and
the link to morbidity and mortality in these patients.
6. Conclusions
A novel ECG-based index, dw, reflecting variation in
ventricular repolarization from the ECG has been evalu-
ated in ESRD patients undergoing HD and compared to
changes in [K+] levels over time. The index dw is highly
correlated with [K+] changes and could potentially be used
as a non-invasive indicator of abnormal [K+] levels.
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